[EN] SMALL MOLECULE MODULATORS OF IL-17 [FR] MODULATEURS À PETITES MOLÉCULES D'IL-17
摘要:
The present invention relates to a compound according to formula (I), and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.
Aminomethyl-substituierte 2,3-Dihydropyrano(2,3-b)pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
申请人:BAYER AG
公开号:EP0519291B1
公开(公告)日:1997-01-08
US5250540A
申请人:——
公开号:US5250540A
公开(公告)日:1993-10-05
Aminomethyl-substituted 2,3-dihydropyrano[2,3-b]pyridines and their use
申请人:Bayer Aktiengesellschaft
公开号:US05250540A1
公开(公告)日:1993-10-05
Aminomethyl-substituted 2,3-dihydropyrano[2,3-b]pyridines can be prepared by alkylation of corresponding amines. The novel aminomethyl-substituted dihydropyrano[2,3-b]pyridines can be used as active ingredients in medicaments, in particular for the treatment of disorders of the central nervous system.
[EN] SMALL MOLECULE MODULATORS OF IL-17<br/>[FR] MODULATEURS À PETITES MOLÉCULES D'IL-17
申请人:[en]LEO PHARMA A/S
公开号:WO2023111181A1
公开(公告)日:2023-06-22
The present invention relates to a compound according to formula (I), and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.